ArticleHeliyon2020
Designing and validating the empowerment scale for the older individuals with chronic obstructive pulmonary disease (ESOCOPD).
Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- Internet use and health among older adults in China: Indirect associations through social participation and physical activity.PloS one · 2026Article
- Coronary Artery Disease Empowerment Scale (CADES): Persian translation and psychometric properties.BMC cardiovascular disorders · 2024Article
- Reliability and validity of the Chinese version of the coronary artery disease empowerment scale (CADES) in patients with coronary artery disease after percutaneous coronary intervention.BMC cardiovascular disorders · 2024Article
- Development and psychometric evaluation of uncertainty about disease and treatment scale in hemodialysis patients: a sequential-exploratory mixed-method study.BMC psychology · 2024Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA standard scale to examine the empowerment status of older individuals with chronic obstructive pulmonary disease (COPD) can be used to assess their ability for self-care and disease management. This study aimed to design and validate the empowerment scale for the older individuals with COPD (ESOCOPD). MATERIALS &
methodsThis study was conducted in two phases with a deductive-inductive approach: a qualitative phase for designing the tool (the grounded theory study re-analysis, a review of texts and interviews) and a quantitative phase for validation of the questionnaire (face and content validity and reliability). Reliability was determined by test-retest and Spearman's correlation coefficient.
resultsBased on the results of the grounded theory study re-analysis and a review of texts and interviews, 47 items were designed, 14 of which were removed in the face and content validity assessment. The total Content validity index and content validity ratio of the questionnaire were found as 0.82 and 0.95, respectively.The final number of items in the scale was 33, and its dimensions included "information seeking, achieving independence, learning to live with COPD, participation in care, having critical thinking, psychosocial capacities management, and achieving goals". Intra-class correlation of questionnaire dimensions was 0.86-0.99.
conclusionsThe ESOCOPD can be used by health care and treatment providers to determine the patient's ability for self-care and disease management because of its small number of items, it's validation, and reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.